Bioanalysis Zone

An author’s perspective: Amanda King-Ahmad on quantitation of the peptide-1 receptor agonist liraglutide


To help provide insight into the recent article published in Bioanalysis: A sensitive method for the quantitation of the peptide-based glucagon-like peptide-1 receptor agonist liraglutide in plasma using microfluidics chromatography tandem MS, we spoke with author Amanda King-Ahmad, Senior Scientist at Pfizer (CT, USA). Amanda explains why she felt this was an important area for bioanalysis and worthy of publication.

Amanda King-Ahmad“I am currently a Senior Scientist in Pfizer’s non-regulated bioanalytical group within the Medicine Design-ADME Sciences group, located in Connecticut, USA. Prior to joining Pfizer, I worked as an onsite-contractor at Bristol Myers-Squibb in both New Jersey and Connecticut. I earned my Bachelor’s degree in chemistry and biology from the University of Vermont (VT, USA), and a Master’s degree in cell and molecular biology from Quinnipiac University (CT, USA).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment